In different tumor cells, TREM2 expression levels vary significantly and can promote or inhibit tumor progression through different signaling pathways, such as NF-κB, JAK/STAT3 and PI3K/Akt signaling pathways. The gene discussed is NFKB1; the disease is neoplasm.